Based on the provided abstracts, there appears to be confusion regarding the CLC gene identity. The abstracts discuss ClC chloride channels and transporters, which are encoded by CLCN genes, not the CLC gene (Charcot-Leyden crystal galectin) mentioned in the query. The ClC family consists of anion channels and anion/proton exchangers that form homo- or heteromeric dimers 1. In mammals, ClC-1 and ClC-2 function as plasma membrane Cl- channels, while ClC-3 through ClC-7 operate as 2Cl-/H+-exchangers in endolysosomal membranes 1. These proteins control electrical excitability, ion homeostasis, and transepithelial transport, with anion/proton exchangers influencing vesicular composition and lysosomal function 1. ClC dysfunction causes diverse human diseases including neurodegeneration, myotonia, renal disorders, and osteopetrosis 1. Specifically, CLCN1 mutations cause myotonia congenita through reduced sarcolemmal chloride conductance 2, while CLCN7 variants can cause osteopetrosis and lysosomal storage diseases 3. However, the provided abstracts do not contain information about the CLC gene (Charcot-Leyden crystal galectin) specified in the query, making it impossible to provide an accurate functional summary for that specific gene.